Assessment of Human Fibrinogen Antigen and Tissue Plasminogen Activator as Hypercoagulability Markers in Type 2 Diabetic Patients in Obio/ Akpor Local Government Area, Rivers State, Nigeria
International Journal of Research and Reports in Hematology · pp. 189–195 · Published 4 Jul 2022
Abstract
This is a case controlled study carried out on type 2 Diabetic Patients in Obio/ Akpor Local Government, Rivers State with the aim of determining the haemostatic status. The haemostatic markers were assessed and compared with apparently healthy control subjects without diabetes. A total of 66 Type 2 diabetic patients (36 females and 30 males) aged between 24 and 77 years; 54 subjects (31 females and 23 males) that were apparently healthy of age between 24 and 76years, enrolled as control, with all participants recruited between November 2019 and January 2020. Human fibrinogen antigen and tissue plasminogen activator were analysed with reagents obtained from Elabscience, Wuhan, China and the test carried out with an ELISA machine (STAT FAX-2100).Results showed a significant increase (p<0.05) respectively in mean tissue plasminogen activator and mean human fibrinogen antigen when compared with control. Also there were strong significant correlations (p<0.05) respectively between human fibrinogen antigen and blood glucose, tissue plasminogen activator and blood glucose.There was no significant differences (p<0.05) observed in tissues plasminogen activator and human fibrinogen antigen between Type 2 Diabetic male and female patients. These two haemastatic markers can be used as a predictor indices for management of hypercoagulability in type 2 diabetic patients.
Cited by 0
No indexed citations yet.
Related research
- Risk Factors of Hypertension among Type 2 Diabetic Patients in Imo state, South East of Nigeria — shares topic coverage
- Patient-Related Factors Affecting Type 2 Diabetes Medication Non-Adherence: A Comprehensive Review of BMI, Knowledge Levels, Treatment Concerns, and Self-Efficacy — shares topic coverage
- The Prevalence of Microalbuinuria & Associated Risk Factors at the Time of Diagnosis among Type 2 Diabetic Patients in Rajshahi City, Bangladesh — shares topic coverage
- Integrating Sglt-2 Inhibitors into the Clinical Management of Type 2 Diabetes Mellitus and Chronic Kidney Disease: Current Evidence and Future Outlook — shares topic coverage
- Comparative Effects of Psyllium and Methylcellulose on LDL Cholesterol and Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.